Weight Loss - Saxenda - Cosmetech

Weight Loss – Saxenda

What is Saxenda?
Saxenda is a weight loss medicine that contains the active substance liraglutide. It is similar to a natural occurring hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after a meal. Saxenda works by acting on receptors in the brain that control your appetite, causing you to feel fuller and less hungry.

What is Saxenda used for?
Saxenda is used for weight loss in addition to diet and exercise in adults aged 18 and above who have:

• BMI of 30 kg/m2 or greater (obese) or

• BMI or 27 kg/m2 and less than 30kg/m2 (overweight) and weight related health problems (such as diabetes, high blood pressure, abnormal levels or fats in the blood or breathing problems during sleep called ‘obstructive sleep apnoea’).

BMI (Body Mass Index) is a measure of your weight in relation to your height. You should only continue using Saxenda if you have lost at least 5% of your initial body weight after 12 weeks on the 3mg/day dose. Consult your healthcare professional before you continue. For more information on Saxenda read the Patient Information Leaflet


How do I take Saxenda?
The active ingredient, liraglutide, comes in a pre-filled Saxenda injection pen. Before you take Saxenda® for the first time, your healthcare professional will show you how to use the Saxenda pen.

Learn how to use the Saxenda injection pen.


What dose of Saxenda do I take?
In your first four weeks of treatment, you will increase your daily Saxenda dose each week. Understand the Saxenda dosing schedule


Saxenda side effects & safety information
As with all medications, Saxenda may cause side effects, although not everyone will experience them. Read about side effects – and how to manage them


Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0845 6005055). Calls may be monitored for training purposes.



Saxenda Consent Form: View PDF

Patient Information: View PDF

Risk Assessment: View PDF

Weight Loss Record: View PDF

Patient Brochure: View PDF

For further information please visit www.saxenda.co.uk